Sanofi: What you need to know
In light of today’s climate, the pharmaceutical industry are at the forefront of healthcare. Technology and digital innovations are being made every day. New ways to treat and manage diseases and illnesses is constantly being researched and developed.
View Life Science Jobs
According to a report published by the World Health Organisation (WHO) it highlights noncommunicable diseases (diseases that are not transmissible directly from one person to another), such as; stroke, Parkinson’s Disease, most cancers, diabetes etc are on the rise. The Director-General of WHO Dr Tedros Adhanom Ghebreyesus, stresses the importance of early detection, diagnosis, prevention and treatment of noncommunicable diseases, especially as they contribute to 7 of the 10 main causes of death on a global scale.
WHO identified the top 10 medical conditions that cause the highest death rates.
- Heart Diseases
- Chronic Obstructive Pulmonary Disease
- Lower Respiratory Infections
- Neonatal conditions
- Trachea, Bronchus, Lung Cancers
- Alzheimer’s Disease and other Dementias
- Diarrhoeal Diseases
- Diabetes Mellitus
- Kidney diseases
There is a huge effort made by pharmaceutical companies to research and develop the best treatment for these major conditions.
One pharmaceutical company who focusses across seven of the major therapeutic areas is Sanofi. Many of the research, development and manufacturing they do address many of the top health conditions that people develop.
Sanofi is a French multinational pharmaceutical company based in Paris, France. They are said to be the 5th largest pharmaceutical organisation in the world (based on their prescription sales), focussing on research and development, manufacturing and marketing of their pharmaceutical drugs.
Sanofi’s work looks heavily at treating the following medical conditions: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines. The work spans over 48 years, however it has gone through a number of mergers and name changes, but by 2011 Sanofi is what we know it to be today.
Sanofi are known to be at the forefront of diabetes and cardiovascular management. They are leaders in the development of insulin treatment and pens. They put the individual at the heart off their research, hence why they produce such a broad range of insulin-based products. Their ethos is to make a difference to people’s lives, the disease they have does not define them or be the end of their life.
Having 100,000+ employees working on making a change the organisation cover – Health and Wellbeing, Cardiovascular and diabetes, but also speciality services that cover, rare blood diseases, rare diseases, neurology, immunology, oncology, and patient support. There healthcare solutions are available in 170 countries they are based in 90 countries worldwide with over 100,000 employees working on creating a solution to several medical conditions.
The technological advancements have made Sanofi research and development innovation possible, their Technology Toolkit covers
- Revolutionary Chemistry
- Novel Antibody Technologies
- Protein Therapeutics
- Genomic Medicine
All these advancements look at ways to target the root causes of diseases and subsequently provide a more precise treatment. However as much as medicine is at the heart of what Sanofi does, they also have a responsibility to overall sustainability of health.
Sanofi are proud to say their ambition is to reverse the course of chronic diseases. They understand that health is not only the medication a person is taking, but also the environment in which we live in is even more so at the core of living a healthy life.
Sanofi have put in place an Environmental Sustainability Program – Plant Mobilisation, which runs throughout their organisation and their entire lifecycle of their products. They work with suppliers to reduce their greenhouse gas emission and create a more sustainable sourcing of raw materials, and have made strives into reducing their carbon output, by making all their sites in France are 100% renewable energy.
The goal for the organisation is to
- Achieve carbon neutrality by 2050
- Limit environmental footprint and adopt circular solutions
- Improve environmental profile of products
The workforce plays such a crucial part of the pharmaceutical industry like any other market. The continued recruitment is vital for the continued effort of research and development. At Cavendish Professionals we recruit pharmaceutical professionals into small and large scale companies. If you have the experience and knowledge get in touch with us to discuss your requirements.
How have the Life Sciences changed over the years?